Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, ...

Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, ...

Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are ...

Disclaimer: This news article is a direct feed from ANI and has not been edited by the News Nation team. The news agency is ...

Several African countries where malaria is widespread are expected to swiftly approve the new medicine following Swissmedic’s ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants ...

Switzerland's health regulator Swissmedic has granted on Tuesday marketing authorization for Novartis Riamet Baby, also known as Coartem Baby, a novel antimalarial medicine specifically designed for ...

Coartem Baby approved for use, first malaria treatment specifically for infants and young children - Anadolu Ajansı ...

Through the initiative, WHO aims to introduce “health taxes” that would raise the prices of tobacco, sugary drinks, and ...

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic.

Swiss federal prosecutors have indicted a Kosovar and a Swiss-Macedonian dual national on terrorism-related charges and spreading the ideology of the banned extremist group Islamic State ...